Kouichi Tamura has received honoraria/lecture fee from AstraZeneca, Novartes, Bayer, Otsuka Pharmaceutical, Boehringer Ingelheim, Fuji Pharma, Kyowa Kirin, Ono Pharmaceutical, Sanwa Kagaku, Mochida Pharmaceutical, Kowa, Eli Lilly, Novo Nordisk, commissioned clinical trials, contract research and joint research funding: AstraZeneca, Bayer, Novartis, Chinook, Otsuka Medical Devices, Novo Nordisk, Terumo, Variatris, and Kowa, and, Scholarship donations: Otsuka Pharmaceutical, Bayer, Mochida Pharmaceutical, and Boehringer Ingelheim
This hormonal response contributes to better glucose control and appetite regulation
Some researchers note that DSIP does not appear to induce tolerance with repeated use, while others recommend cycling as a precautionary measure
doi: 10.2147/jbm.s159295
More than 70% of people taking the higher Wegovy dose reported issues such as nausea, vomiting or constipation